Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2021 | Exciting myeloma updates coming soon at EHA 2021

Enrique M. Ocio, MD, PhD, Marqués de Valdecilla University Hospital, Santander, Spain, shares what he’s looking forward to at the virtual European Hematology Association (EHA) Congress 2021, in particular highlighting updates on new combinations in the frontline setting for multiple myeloma, and novel data on bispecific antibodies, antibody-drug conjugates and chimeric antigen receptor T-cell (CAR-T) therapy.

Disclosures

Enrique M. Ocio, MD, PhD has received honoraria or consultancy fees from Janssen, BMS, Sanofi, GSK, Oncopeptides, Amgen, Takeda, Secura-Bio, MSD and Mundipharma-EDO.